Pheno-seq - Linking Visual Features and Gene Expression in 3D Cell Culture Systems
Authors
Affiliations
Patient-derived 3D cell culture systems are currently advancing cancer research since they potentiate the molecular analysis of tissue-like properties and drug response under well-defined conditions. However, our understanding of the relationship between the heterogeneity of morphological phenotypes and the underlying transcriptome is still limited. To address this issue, we here introduce "pheno-seq" to directly link visual features of 3D cell culture systems with profiling their transcriptome. As prototypic applications breast and colorectal cancer (CRC) spheroids were analyzed by pheno-seq. We identified characteristic gene expression signatures of epithelial-to-mesenchymal transition that are associated with invasive growth behavior of clonal breast cancer spheroids. Furthermore, we linked long-term proliferative capacity in a patient-derived model of CRC to a lowly abundant PROX1-positive cancer stem cell subtype. We anticipate that the ability to integrate transcriptome analysis and morphological patho-phenotypes of cancer cells will provide novel insight on the molecular origins of intratumor heterogeneity.
Approaches for single-cell RNA sequencing across tissues and cell types.
Sant P, Rippe K, Mallm J Transcription. 2023; 14(3-5):127-145.
PMID: 37062951 PMC: 10807473. DOI: 10.1080/21541264.2023.2200721.
Freckmann E, Sandilands E, Cumming E, Neilson M, Roman-Fernandez A, Nikolatou K Nat Commun. 2022; 13(1):5317.
PMID: 36085324 PMC: 9463449. DOI: 10.1038/s41467-022-32958-x.
Donath S, Angerstein L, Gentemann L, Muller D, Seidler A, Jesinghaus C Cells. 2022; 11(7).
PMID: 35406708 PMC: 8998079. DOI: 10.3390/cells11071143.
Deterministic scRNA-seq captures variation in intestinal crypt and organoid composition.
Bues J, Biocanin M, Pezoldt J, Dainese R, Chrisnandy A, Rezakhani S Nat Methods. 2022; 19(3):323-330.
PMID: 35165449 DOI: 10.1038/s41592-021-01391-1.
Organoids in image-based phenotypic chemical screens.
Lukonin I, Zinner M, Liberali P Exp Mol Med. 2021; 53(10):1495-1502.
PMID: 34663938 PMC: 8569209. DOI: 10.1038/s12276-021-00641-8.